“Letter to The Editor: Can Eptifibatide Rewrite the NSTEMI Story? (Eptifibatide vs. Standard Care for NSTEMI: A 5‐Year Analysis of Major Adverse Cardiovascular Events)”
Year: 2025
Type: letter
Abstract: Data sharing does not apply to this article as no data sets were generated during the current study; all data were sourced from published literature.
DOI: 10.1002/ccd.70304
Institution: Shaikh Zayed Postgraduate Medical Institute
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4416062002
